Medela Establishes Drainology™ as a Global Hub to Advance Evidence-Based Chest Drain Management

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Medela Establishes Drainology™ as a Global Hub to Advance Evidence-Based Chest Drain ManagementAuthor of the article:Drainology™ is a scientific initiative dedicated to advancing evidence-based chest drain management through research, education and clinical collaboration. GNWBaar, Switzerland, Oct. 07, 2026 (GLOBE NEWSWIRE) — Medela, a global leader in healthcare technology, today announced the expansion of Drainology™, a scientific initiative dedicated to advancing evidence-based chest drain management through research, education and clinical collaboration. With new digital channels, expert-led educational resources and scientific events, the initiative will broaden access to knowledge and create additional opportunities for exchange and collaboration across the global healthcare community.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountThis advertisement has not loaded yet, but your article continues below.Drainology™ will also be featured as part of Medela’s presence at the 40th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting, taking place October 7–10, 2026, in Barcelona, Spain.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againAlthough chest drainage therapy is a fundamental component of cardiothoracic care, clinical practice continues to vary across healthcare settings. Drainology™ aims to support healthcare professionals by providing an evidence-based platform for education, expert dialogue, and practical insights.Guided by an independent scientific board and sponsored by Medela, Drainology™ was established to encourage scientific exchange, promote evidence-based approaches, and help translate emerging knowledge into clinical practice.Through Drainology™, Medela reinforces its commitment to clinical excellence in chest drainage therapy by supporting the generation, dissemination and application of scientific evidence. It serves as a global resource for clinicians who seek to strengthen decision-making, reduce practice variability and improve patient outcomes.This advertisement has not loaded yet, but your article continues below.“At Medela, we know that technology alone does not improve patient care. Clinicians also need access to strong evidence, clinical expertise, and exchange with their peers,” said Thomas Golücke, CEO of Medela. “With Drainology™, we want to help advance the science of chest drain management, bring these elements together and support healthcare professionals in translating the latest knowledge into everyday practice. This reflects Medela’s broader commitment to combining clinical understanding with solutions that enable more informed and effective care and ultimately improve the patient experience.”Through Drainology™, Medela collaborates with leading specialists in cardiothoracic surgery to foster scientific dialogue, support clinical decision-making through literature reviews and expert insights, share evidence-based knowledge and promote best practices in chest drain management.The Drainology™ initiative is supported by an independent scientific board comprising Stephen D. Cassivi, Daniel Engelman, Wentao Fang, Eric Lim, Kevin W. Lobdell, Gloria Färber, and Alan D. L. Sihoe. The board provides expert guidance on educational and scientific activities, while Medela serves as sponsor and provides operational support.This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.“The future of cardiac surgery chest drain management must evolve from tradition to precision through networked learning and AI-augmented care. When we replace habit with continuous, data-driven insights, we will reduce complications like Retained Blood Syndrome and enhance recovery,” said Kevin W. Lobdell, MD, Professor & System Director CV Surgical Quality, Education, and Research at Atrium Health, and Drainology™ board member.Creating a Global Hub for Scientific Exchange in Chest Drain ManagementDrainology™ provides healthcare professionals with access to expert-led educational content, scientific resources and opportunities for collaboration and global best-practice sharing. Through scientific sessions and symposia at leading conferences, as well as its website, newsletter, and LinkedIn presence, the initiative aims to facilitate scientific dialogue, encourage collaboration across the global healthcare community and support the continued advancement of chest drain management.Healthcare professionals are encouraged to visit www.drainology.org, follow the Drainology™ LinkedIn page, and subscribe to the Drainology™ newsletter for educational content, expert perspectives, and updates from the platform.This advertisement has not loaded yet, but your article continues below.Through advancing research, observing natural behavior and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides leading research-based breast milk feeding products, healthcare solutions for hospitals, and clinical education. Medela is dedicated to building better health outcomes, simplifying and improving life, and developing breakthroughs that help moms, babies and patients live their life to the fullest. For more information, visit medela.com.Medela Media.Inquiries@medela.com This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.